Question 1
Each actuation delivers 0.25 mL of product at a concentration of 50 mg per mL. How many milligrams are delivered per actuation?
Correct Answer:
12.5 mg
Explanation:
Mass delivered equals volume times concentration, because concentration tells you how many milligrams are in each milliliter, and the volume tells you how many milliliters you’re using. So the amount of drug per actuation is 0.25 mL × 50 mg/mL = 12.5 mg. This also makes sense because a quarter of a milliliter of a solution with 50 mg in 1 mL contains a quarter of 50 mg, which is 12.5 mg.
Question 2
Which option pair correctly assigns the definitions for Quality Control and Quality Assurance?
Correct Answer:
Quality Control; Quality Assurance
Explanation:
Quality assurance is process-oriented, aiming to prevent defects by improving the development and production processes. Quality control is product-oriented, focusing on identifying defects in the final product through testing and inspection. Because QA works to prevent problems by refining how things are made, while QC checks the actual product for defects, the correct pairing assigns the defects-detection role toQuality Control and the process-improvement role to Quality Assurance. The other option would swap these roles, which doesn’t fit how these concepts are defined.
Question 3
When a potency test for a compound in production is out of specification, which action should NOT be performed?
Correct Answer:
Dispense the product
Explanation:
Potency must meet specification before any product is released. If potency is out of specification during production, the immediate step is to quarantine the affected material to prevent its distribution. Dispensing the product would allow a subpotent or inconsistent product to reach patients, which is unsafe and violates regulatory requirements. After quarantine, conduct a root cause analysis to identify why potency deviated—factors could include process variation, raw material quality, equipment calibration, or an analytical method issue. Then implement corrective and preventive actions (CAPA) to address the root cause and strengthen the system, and document all findings and actions in CAPA records. The final disposition of the quarantined material should follow the investigation and CAPA outcomes, which may include retesting, rework, or disposal.
Question 4
Which statement about full-face respirators used in hazardous drug handling is correct?
Correct Answer:
They provide eye and face protection and must be used during deep cleaning of the C-PEC, in the event of a spill larger than the spill kit can contain, or when splashes can occur.
Explanation:
Full-face respirators are used when there is a real risk of exposure to hazardous drugs through splashes or aerosols, providing both eye protection and a seal around the entire face to protect the respiratory tract. This is crucial during deep cleaning of the C-PEC, when residues can become airborne, during spills larger than what the spill kit can handle, or whenever splashes could occur. In these situations, protecting both eyes and breathing is essential because exposure can happen through inhalation or ocular contact, and standard eye protection alone would not prevent inhalation of hazardous drug aerosols. They are not required for routine handling outside the C-PEC, where less intensive protection is typically adequate, and they are not unnecessary for spill cleanups; the need for respiratory protection rises when the spill is large or splashes are anticipated.
Question 5
Which option shows the exact product and lot number match for Product XYABA 2%?
Correct Answer:
Product XYABA 2%; Lot# 0101202225
Explanation:
Exact product identity and lot-number traceability are being tested. The only option that has both the correct product and the exact lot number is Product XYABA 2% with Lot# 0101202225. The other choices fail because they either change the product name (XYABAA), the strength (1% instead of 2%), or provide an incorrect lot number (different digits or format). Using the exact combination is essential for accurate identification, traceability, and safety in handling and recalls.
Question 1
Exam overview

About this Exam

Prepare with the Curexa Certification Practice Test practice quiz. This question bank includes 10 questions covering product, actuation, many, quality, and control. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Curexa Certification Practice Test

This practice set contains 10 questions from the matching question bank and focuses on product, actuation, many, quality, and control. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions